Liu Z, Liu Y, Kang X, Li L, Xiang Y
Pharmaceutics. 2025; 17(2).
PMID: 40006565
PMC: 11859411.
DOI: 10.3390/pharmaceutics17020198.
Chen R, Yao Z, Jiang L, Hu J
Discov Oncol. 2025; 16(1):76.
PMID: 39841334
PMC: 11754555.
DOI: 10.1007/s12672-025-01827-6.
Iannitti R, Mascanzoni F, Colanzi A, Spano D
Front Cell Dev Biol. 2025; 12():1513472.
PMID: 39839669
PMC: 11747491.
DOI: 10.3389/fcell.2024.1513472.
Liu Y, Lin T, Chong K, Chen G, Kuo C, Lin Y
Cell Commun Signal. 2025; 23(1):22.
PMID: 39800687
PMC: 11727508.
DOI: 10.1186/s12964-024-02010-0.
Broekhuis J, Lu D, Aryal R, Matsumoto Y, Pepi L, Chaves N
Biomolecules. 2025; 14(12.
PMID: 39766189
PMC: 11727208.
DOI: 10.3390/biom14121482.
Quadrant darkfield for label-free imaging of intracellular puncta.
Moustafa T, Belote R, Polanco E, Judson-Torres R, Zangle T
J Biomed Opt. 2024; 29(11):116501.
PMID: 39618547
PMC: 11605245.
DOI: 10.1117/1.JBO.29.11.116501.
GCC2 promotes non-small cell lung cancer progression by maintaining Golgi apparatus integrity and stimulating EGFR signaling pathways.
Kim M, Jeong H, Choi B, Park J, Shin G, Jung J
Sci Rep. 2024; 14(1):28926.
PMID: 39572606
PMC: 11582359.
DOI: 10.1038/s41598-024-75316-1.
Prognostic value and anti-tumor immunity role of in pan-cancer: a bioinformatics study.
Wang H, Wang Y, Tan P, Liu Y, Zhou S, Ma W
Transl Cancer Res. 2024; 13(10):5429-5445.
PMID: 39525003
PMC: 11543038.
DOI: 10.21037/tcr-24-258.
Quadrant darkfield (QDF) for label-free imaging of intracellular puncta.
Moustafa T, Belote R, Polanco E, Judson-Torres R, Zangle T
bioRxiv. 2024; .
PMID: 39149239
PMC: 11326191.
DOI: 10.1101/2024.08.05.606686.
Morphological determination of localization and function of Golgi proteins.
Xing Y, Jian Y, Zhao X, Zhang Y, Zhang Z, Zhang X
Biophys Rep. 2024; 10(2):121-132.
PMID: 38774352
PMC: 11103716.
DOI: 10.52601/bpr.2024.240008.
Functional analysis and validation of oncodrive gene AP3S1 in ovarian cancer through filtering of mutation data from whole-exome sequencing.
Kong D, Wu Y, Liu Q, Huang C, Wang T, Huang Z
Eur J Med Res. 2024; 29(1):231.
PMID: 38609993
PMC: 11015698.
DOI: 10.1186/s40001-024-01814-7.
Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study.
Pinkeova A, Tomikova A, Bertokova A, Fabinyova E, Bartova R, Jane E
PLoS One. 2024; 19(3):e0300430.
PMID: 38498504
PMC: 10947713.
DOI: 10.1371/journal.pone.0300430.
Identification of ACBD3 as a new molecular biomarker in pan-cancers through bioinformatic analysis: a preclinical study.
Ma X, Huang S, Shi H, Luo R, Luo B, Tan Z
Eur J Med Res. 2023; 28(1):590.
PMID: 38098097
PMC: 10720239.
DOI: 10.1186/s40001-023-01576-8.
CRISPR screens and lectin microarrays identify novel high mannose N-glycan regulators.
Tsui C, Twells N, Doan E, Woo J, Khosrojerdi N, Brooks J
bioRxiv. 2023; .
PMID: 37961200
PMC: 10634773.
DOI: 10.1101/2023.10.23.563662.
The Structural Proteins of Membrane Rafts, Caveolins and Flotillins, in Lung Cancer: More Than Just Scaffold Elements.
Saldana-Villa A, Lara-Lemus R
Int J Med Sci. 2023; 20(13):1662-1670.
PMID: 37928877
PMC: 10620868.
DOI: 10.7150/ijms.87836.
Golgi's Role in the Development of Possible New Therapies in Cancer.
Vlad D, Dumitrascu D, Dumitrascu A
Cells. 2023; 12(11).
PMID: 37296620
PMC: 10252985.
DOI: 10.3390/cells12111499.
Adaptively Integrative Association between Multivariate Phenotypes and Transcriptomic Data for Complex Diseases.
Li Y, Fang Y, Chang H, Gorczyca M, Liu P, Tseng G
Genes (Basel). 2023; 14(4).
PMID: 37107556
PMC: 10138055.
DOI: 10.3390/genes14040798.
EMT-activated secretory and endocytic vesicular trafficking programs underlie a vulnerability to PI4K2A antagonism in lung cancer.
Tan X, Xiao G, Wang S, Shi L, Zhao Y, Liu X
J Clin Invest. 2023; 133(7).
PMID: 36757799
PMC: 10065074.
DOI: 10.1172/JCI165863.
Golgi Stress Response: New Insights into the Pathogenesis and Therapeutic Targets of Human Diseases.
Kim W, Choi W, Deshar B, Kang S, Kim J
Mol Cells. 2022; 46(4):191-199.
PMID: 36574967
PMC: 10086555.
DOI: 10.14348/molcells.2023.2152.
Impad1 and Syt11 work in an epistatic pathway that regulates EMT-mediated vesicular trafficking to drive lung cancer invasion and metastasis.
Bajaj R, Rodriguez B, Russell W, Warner A, Diao L, Wang J
Cell Rep. 2022; 40(13):111429.
PMID: 36170810
PMC: 9665355.
DOI: 10.1016/j.celrep.2022.111429.